<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36746939</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.</ArticleTitle><Pagination><StartPage>603</StartPage><MedlinePgn>603</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">603</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-36186-9</ELocationID><Abstract><AbstractText>Spinobulbar muscular atrophy (SBMA) is caused by CAG expansions in the androgen receptor gene. Androgen binding to polyQ-expanded androgen receptor triggers SBMA through a combination of toxic gain-of-function and loss-of-function mechanisms. Leveraging cell lines, mice, and patient-derived specimens, we show that androgen receptor co-regulators lysine-specific demethylase 1 (LSD1) and protein arginine methyltransferase 6 (PRMT6) are overexpressed in an androgen-dependent manner specifically in the skeletal muscle of SBMA patients and mice. LSD1 and PRMT6 cooperatively and synergistically transactivate androgen receptor, and their effect is enhanced by expanded polyQ. Pharmacological and genetic silencing of LSD1 and PRMT6 attenuates polyQ-expanded androgen receptor transactivation in SBMA cells and suppresses toxicity in SBMA flies, and a preclinical approach based on miRNA-mediated silencing of LSD1 and PRMT6 attenuates disease manifestations in SBMA mice. These observations suggest that targeting overexpressed co-regulators can attenuate androgen receptor toxic gain-of-function without exacerbating loss-of-function, highlighting a potential therapeutic strategy for patients with SBMA.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Prakasam</LastName><ForeName>Ramachandran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dulbecco Telethon Institute at the Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bonadiman</LastName><ForeName>Angela</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3873-1258</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Andreotti</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccaro</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalfovo</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9760-7655</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchioretti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathy</LastName><ForeName>Debasmita</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petris</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2420-6359</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Saffron Walden, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Eric N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migazzi</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0851-2903</Identifier><AffiliationInfo><Affiliation>Dulbecco Telethon Institute at the Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosatto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5966-8131</Identifier><AffiliationInfo><Affiliation>Dulbecco Telethon Institute at the Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cereseto</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4453-2597</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battaglioli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Wooi Fang</ForeName><Initials>WF</Initials><Identifier Source="ORCID">0000-0002-1238-3040</Identifier><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Developmental and Regenerative Medicine, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Developmental and Regenerative Medicine, Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sambataro</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourshafie</LastName><ForeName>Naemeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanel</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4855-8620</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Udai Bhan</ForeName><Initials>UB</Initials><Identifier Source="ORCID">0000-0002-6267-0179</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contestabile</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5417-4722</Identifier><AffiliationInfo><Affiliation>Istituto Italiano di Tecnologia, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronzitti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9184-0210</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, Univ Evry, Inserm, Genethon, Evry, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genethon, 91000, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basso</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9278-8960</Identifier><AffiliationInfo><Affiliation>Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy. manuela.basso@unitn.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8634-0767</Identifier><AffiliationInfo><Affiliation>Dulbecco Telethon Institute at the Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine, Padova, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center, Padova, Italy. maria.pennuto@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS111768</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.11.-</RegistryNumber><NameOfSubstance UI="D056466">Histone Demethylases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004175" MajorTopicYN="Y">Diptera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073659" MajorTopicYN="N">Gain of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056466" MajorTopicYN="N">Histone Demethylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020966" MajorTopicYN="Y">Muscular Disorders, Atrophic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>M.P., M.B., G.R., and A.C. are named as co-inventors on the patent application Italian Priority N. 102022000026595 &#x201c;New inhibitors of epigenetic regulators/nuovi inibitori di regolatori epigenetici&#x201d;. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36746939</ArticleId><ArticleId IdType="pmc">PMC9902531</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-36186-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-36186-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007;30:575&#x2013;621. doi: 10.1146/annurev.neuro.29.051605.113042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.29.051605.113042</ArticleId><ArticleId IdType="pubmed">17417937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara, H. A family of progressive bulbar palsy. Aichi. Med. J.16, 3&#x2013;4 (1897).</Citation></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R, et al. Beyond motor neurons: expanding the clinical spectrum in Kennedy&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2018;89:808&#x2013;812. doi: 10.1136/jnnp-2017-316961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejager S, et al. A comprehensive endocrine description of Kennedy&#x2019;s disease revealing androgen insensitivity linked to CAG repeat length. J. Clin. Endocrinol. Metab. 2002;87:3893&#x2013;3901.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161529</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, et al. Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J. Neurol. Neurosurg. Psychiatry. 2016;87:810&#x2013;816. doi: 10.1136/jnnp-2015-311305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311305</ArticleId><ArticleId IdType="pmc">PMC4975824</ArticleId><ArticleId IdType="pubmed">26503015</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854. doi: 10.1016/S0896-6273(02)00834-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 2004;24:4778&#x2013;4786. doi: 10.1523/JNEUROSCI.0808-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0808-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 2006;116:2663&#x2013;2672. doi: 10.1172/JCI28773..</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773.</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447:859&#x2013;863. doi: 10.1038/nature05853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05853</ArticleId><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 2002;59:770&#x2013;772. doi: 10.1212/WNL.59.5.770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.5.770</ArticleId><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, et al. An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy. Muscle Nerve. 2013;47:816&#x2013;822. doi: 10.1002/mus.23759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23759</ArticleId><ArticleId IdType="pubmed">23512333</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E, et al. Rescue of metabolic alterations in AR113Q skeletal muscle by peripheral androgen receptor gene silencing. Cell Rep. 2016;17:125&#x2013;136. doi: 10.1016/j.celrep.2016.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.084</ArticleId><ArticleId IdType="pmc">PMC5076565</ArticleId><ArticleId IdType="pubmed">27681426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 2002;11:1967&#x2013;1976. doi: 10.1093/hmg/11.17.1967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.17.1967</ArticleId><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 2016;132:127&#x2013;144. doi: 10.1007/s00401-016-1550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936&#x2013;952. doi: 10.1016/j.neuron.2010.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.034</ArticleId><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Badders NM, et al. Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat. Med. 2018;24:427&#x2013;437. doi: 10.1038/nm.4500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4500</ArticleId><ArticleId IdType="pmc">PMC5975249</ArticleId><ArticleId IdType="pubmed">29505030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, et al. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 2007;13:348&#x2013;353. doi: 10.1038/nm1547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1547</ArticleId><ArticleId IdType="pubmed">17334372</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C, et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron. 2015;85:88&#x2013;100. doi: 10.1016/j.neuron.2014.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.031</ArticleId><ArticleId IdType="pmc">PMC4305189</ArticleId><ArticleId IdType="pubmed">25569348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Chung HH, Woo AR, Lin VC. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor alpha via distinct mechanisms. Biochim. Biophys. Acta. 2014;1843:2067&#x2013;2078. doi: 10.1016/j.bbamcr.2014.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2014.04.008</ArticleId><ArticleId IdType="pubmed">24742914</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira FQ, et al. Deregulated expression of selected histone methylases and demethylases in prostate carcinoma. Endocr. Relat. Cancer. 2014;21:51&#x2013;61. doi: 10.1530/ERC-13-0375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ERC-13-0375</ArticleId><ArticleId IdType="pubmed">24200674</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimatsu M, et al. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer. 2011;128:562&#x2013;573. doi: 10.1002/ijc.25366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25366</ArticleId><ArticleId IdType="pubmed">20473859</ArticleId></ArticleIdList></Reference><Reference><Citation>Coviello AD, et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet. 2012;8:e1002805. doi: 10.1371/journal.pgen.1002805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002805</ArticleId><ArticleId IdType="pmc">PMC3400553</ArticleId><ArticleId IdType="pubmed">22829776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo A, et al. Chrysanthemi Zawadskii var. Latilobum attenuates obesity-induced skeletal muscle atrophy via regulation of PRMTs in skeletal muscle of mice. Int. J. Mol. Sci. 2020;21:2811. doi: 10.3390/ijms21082811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21082811</ArticleId><ArticleId IdType="pmc">PMC7215836</ArticleId><ArticleId IdType="pubmed">32316567</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzger E, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature. 2005;437:436&#x2013;439. doi: 10.1038/nature04020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04020</ArticleId><ArticleId IdType="pubmed">16079795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahl P, et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 2006;66:11341&#x2013;11347. doi: 10.1158/0008-5472.CAN-06-1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-06-1570</ArticleId><ArticleId IdType="pubmed">17145880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet M, et al. Polyglutamine-expanded androgen receptor alteration of skeletal muscle homeostasis and myonuclear aggregation are affected by sex, age and muscle metabolism. Cells. 2020;9:325. doi: 10.3390/cells9020325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020325</ArticleId><ArticleId IdType="pmc">PMC7072234</ArticleId><ArticleId IdType="pubmed">32019272</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchioretti, C. et al. Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle. Nat. Commun. 10.1038/s41467-023-36185-w.</Citation></Reference><Reference><Citation>Pennuto M, Basso M. In vitro and in vivo modeling of spinal and bulbar muscular atrophy. J. Mol. Neurosci. 2016;58:365&#x2013;373. doi: 10.1007/s12031-015-0677-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0677-4</ArticleId><ArticleId IdType="pubmed">26614347</ArticleId></ArticleIdList></Reference><Reference><Citation>Milioto C, et al. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci. Rep. 2017;7:41046. doi: 10.1038/srep41046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41046</ArticleId><ArticleId IdType="pmc">PMC5259768</ArticleId><ArticleId IdType="pubmed">28117338</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WF, et al. Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci. Adv. 2021;7:eabi6896. doi: 10.1126/sciadv.abi6896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abi6896</ArticleId><ArticleId IdType="pmc">PMC8378820</ArticleId><ArticleId IdType="pubmed">34417184</ArticleId></ArticleIdList></Reference><Reference><Citation>Zibetti C, et al. Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system. J. Neurosci. 2010;30:2521&#x2013;2532. doi: 10.1523/JNEUROSCI.5500-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5500-09.2010</ArticleId><ArticleId IdType="pmc">PMC6634524</ArticleId><ArticleId IdType="pubmed">20164337</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, et al. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. J. Neurosci. Res. 2010;88:2207&#x2013;2216. doi: 10.1002/jnr.22389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22389</ArticleId><ArticleId IdType="pmc">PMC3881232</ArticleId><ArticleId IdType="pubmed">20336775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013;8:2281&#x2013;2308. doi: 10.1038/nprot.2013.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.143</ArticleId><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Heery DM, Kalkhoven E, Hoare S, Parker MG. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997;387:733&#x2013;736. doi: 10.1038/42750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42750</ArticleId><ArticleId IdType="pubmed">9192902</ArticleId></ArticleIdList></Reference><Reference><Citation>Guccione E, et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature. 2007;449:933&#x2013;937. doi: 10.1038/nature06166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06166</ArticleId><ArticleId IdType="pubmed">17898714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 2006;13:563&#x2013;567. doi: 10.1016/j.chembiol.2006.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2006.05.004</ArticleId><ArticleId IdType="pubmed">16793513</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol. Ther. 2009;17:169&#x2013;175. doi: 10.1038/mt.2008.231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2008.231</ArticleId><ArticleId IdType="pmc">PMC2834985</ArticleId><ArticleId IdType="pubmed">19002161</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JN, et al. Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Ther. 2011;18:666&#x2013;673. doi: 10.1038/gt.2011.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2011.10</ArticleId><ArticleId IdType="pmc">PMC3131434</ArticleId><ArticleId IdType="pubmed">21368900</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride JL, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl Acad. Sci. USA. 2008;105:5868&#x2013;5873. doi: 10.1073/pnas.0801775105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801775105</ArticleId><ArticleId IdType="pmc">PMC2311380</ArticleId><ArticleId IdType="pubmed">18398004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 2009;41:125&#x2013;129. doi: 10.1038/ng.268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.268</ArticleId><ArticleId IdType="pubmed">19098913</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan B, et al. LSD1 downregulates p21 expression in vascular smooth muscle cells and promotes neointima formation. Biochem Pharm. 2022;198:114947. doi: 10.1016/j.bcp.2022.114947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.114947</ArticleId><ArticleId IdType="pubmed">35143753</ArticleId></ArticleIdList></Reference><Reference><Citation>Neault M, Mallette FA, Vogel G, Michaud-Levesque J, Richard S. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res. 2012;40:9513&#x2013;9521. doi: 10.1093/nar/gks764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks764</ArticleId><ArticleId IdType="pmc">PMC3479207</ArticleId><ArticleId IdType="pubmed">22904064</ArticleId></ArticleIdList></Reference><Reference><Citation>Halievski K, Mo K, Westwood JT, Monks DA. Transcriptional profile of muscle following acute induction of symptoms in a mouse model of Kennedy&#x2019;s disease/spinobulbar muscular atrophy. PLoS ONE. 2015;10:e0118120. doi: 10.1371/journal.pone.0118120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118120</ArticleId><ArticleId IdType="pmc">PMC4341878</ArticleId><ArticleId IdType="pubmed">25719894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo K, et al. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS ONE. 2010;5:e12922. doi: 10.1371/journal.pone.0012922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012922</ArticleId><ArticleId IdType="pmc">PMC2944863</ArticleId><ArticleId IdType="pubmed">20886071</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean HE, et al. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J. 2008;22:2676&#x2013;2689. doi: 10.1096/fj.08-105726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-105726</ArticleId><ArticleId IdType="pubmed">18390925</ArticleId></ArticleIdList></Reference><Reference><Citation>Anan K, et al. LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation. Nucleic Acids Res. 2018;46:5441&#x2013;5454. doi: 10.1093/nar/gky234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky234</ArticleId><ArticleId IdType="pmc">PMC6009677</ArticleId><ArticleId IdType="pubmed">29618057</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, et al. Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors. Biochem. Biophys. Res. Commun. 2010;401:327&#x2013;332. doi: 10.1016/j.bbrc.2010.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.09.014</ArticleId><ArticleId IdType="pubmed">20833138</ArticleId></ArticleIdList></Reference><Reference><Citation>Scionti I, et al. LSD1 controls timely MyoD expression via MyoD core enhancer transcription. Cell Rep. 2017;18:1996&#x2013;2006. doi: 10.1016/j.celrep.2017.01.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.078</ArticleId><ArticleId IdType="pubmed">28228264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosio S, et al. Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway. Oncogene. 2017;36:6701&#x2013;6711. doi: 10.1038/onc.2017.267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2017.267</ArticleId><ArticleId IdType="pmc">PMC5717079</ArticleId><ArticleId IdType="pubmed">28783174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling. Acta Pharm. Sin. B. 2019;9:324&#x2013;334. doi: 10.1016/j.apsb.2018.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2018.10.006</ArticleId><ArticleId IdType="pmc">PMC6437640</ArticleId><ArticleId IdType="pubmed">30972280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control. Nat. Neurosci. 2015;18:1256&#x2013;1264. doi: 10.1038/nn.4069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4069</ArticleId><ArticleId IdType="pmc">PMC4625987</ArticleId><ArticleId IdType="pubmed">26214369</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri CE, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 2012;44:685&#x2013;689. doi: 10.1038/ng.2279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2279</ArticleId><ArticleId IdType="pmc">PMC3673022</ArticleId><ArticleId IdType="pubmed">22610119</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11&#x2013;22. doi: 10.1016/j.ccr.2010.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2010.05.026</ArticleId><ArticleId IdType="pmc">PMC3198787</ArticleId><ArticleId IdType="pubmed">20579941</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, et al. A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. Elife. 2017;6:e28482. doi: 10.7554/eLife.28482.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.28482</ArticleId><ArticleId IdType="pmc">PMC5608510</ArticleId><ArticleId IdType="pubmed">28826481</ArticleId></ArticleIdList></Reference><Reference><Citation>Senapati D, Kumari S, Heemers HV. Androgen receptor co-regulation in prostate cancer. Asian J. Urol. 2020;7:219&#x2013;232. doi: 10.1016/j.ajur.2019.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajur.2019.09.005</ArticleId><ArticleId IdType="pmc">PMC7385509</ArticleId><ArticleId IdType="pubmed">32742924</ArticleId></ArticleIdList></Reference><Reference><Citation>Heemers HV, et al. Androgen modulation of coregulator expression in prostate cancer cells. Mol. Endocrinol. 2009;23:572&#x2013;583. doi: 10.1210/me.2008-0363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2008-0363</ArticleId><ArticleId IdType="pmc">PMC2667711</ArticleId><ArticleId IdType="pubmed">19164447</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafi AA, et al. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. Nat. Commun. 2021;12:401. doi: 10.1038/s41467-020-20513-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20513-5</ArticleId><ArticleId IdType="pmc">PMC7810852</ArticleId><ArticleId IdType="pubmed">33452241</ArticleId></ArticleIdList></Reference><Reference><Citation>Guber RD, et al. Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy. Neurology. 2017;89:2481&#x2013;2490. doi: 10.1212/WNL.0000000000004748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004748</ArticleId><ArticleId IdType="pmc">PMC5729799</ArticleId><ArticleId IdType="pubmed">29142082</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi S, Pennuto M. Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Front. Neuroendocrinol. 2011;32:416&#x2013;425. doi: 10.1016/j.yfrne.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2011.06.003</ArticleId><ArticleId IdType="pubmed">21745497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph T, Beuch S, Reuter G. Lysine-specific histone demethylase LSD1 and the dynamic control of chromatin. Biol. Chem. 2013;394:1019&#x2013;1028. doi: 10.1515/hsz-2013-0119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2013-0119</ArticleId><ArticleId IdType="pubmed">23612539</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Andaloussi N, et al. Arginine methylation regulates DNA polymerase beta. Mol. Cell. 2006;22:51&#x2013;62. doi: 10.1016/j.molcel.2006.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.02.013</ArticleId><ArticleId IdType="pubmed">16600869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WL, Wang L, Liu LX, Wang XL. Effect of phosphorylation and methylation on the function of the p16(INK4a) protein in non-small cell lung cancer A549 cells. Oncol. Lett. 2015;10:2277&#x2013;2282. doi: 10.3892/ol.2015.3617.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2015.3617</ArticleId><ArticleId IdType="pmc">PMC4579901</ArticleId><ArticleId IdType="pubmed">26622834</ArticleId></ArticleIdList></Reference><Reference><Citation>Han HS, et al. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism. Sci. Signal. 2014;7:ra19. doi: 10.1126/scisignal.2004479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2004479</ArticleId><ArticleId IdType="pubmed">24570487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Wang Z, Narayanan N, Yang Y. Arginine methylation of the C-terminus RGG motif promotes TOP3B topoisomerase activity and stress granule localization. Nucleic Acids Res. 2018;46:3061&#x2013;3074. doi: 10.1093/nar/gky103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky103</ArticleId><ArticleId IdType="pmc">PMC5888246</ArticleId><ArticleId IdType="pubmed">29471495</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakakido M, et al. PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents. Oncotarget. 2015;6:30957&#x2013;30967. doi: 10.18632/oncotarget.5143.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5143</ArticleId><ArticleId IdType="pmc">PMC4741580</ArticleId><ArticleId IdType="pubmed">26436589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgarra R, et al. The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J. Biol. Chem. 2006;281:3764&#x2013;3772. doi: 10.1074/jbc.M510231200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M510231200</ArticleId><ArticleId IdType="pubmed">16293633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontaki H, Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol. Cell. 2010;39:152&#x2013;160. doi: 10.1016/j.molcel.2010.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.06.006</ArticleId><ArticleId IdType="pubmed">20603083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho HS, et al. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res. 2011;71:655&#x2013;660. doi: 10.1158/0008-5472.CAN-10-2446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-2446</ArticleId><ArticleId IdType="pubmed">21115810</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, et al. p53 is regulated by the lysine demethylase LSD1. Nature. 2007;449:105&#x2013;108. doi: 10.1038/nature06092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06092</ArticleId><ArticleId IdType="pubmed">17805299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. Methylation-dependent regulation of HIF-1alpha stability restricts retinal and tumour angiogenesis. Nat. Commun. 2016;7:10347. doi: 10.1038/ncomms10347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10347</ArticleId><ArticleId IdType="pmc">PMC4735525</ArticleId><ArticleId IdType="pubmed">26757928</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnesecchi J, Cerutti C, Vanacker JM, Forcet C. ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner. PLoS ONE. 2017;12:e0188871. doi: 10.1371/journal.pone.0188871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188871</ArticleId><ArticleId IdType="pmc">PMC5708767</ArticleId><ArticleId IdType="pubmed">29190800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, et al. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer. Nat. Genet. 2020;52:1011&#x2013;1017. doi: 10.1038/s41588-020-0681-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0681-7</ArticleId><ArticleId IdType="pmc">PMC7541538</ArticleId><ArticleId IdType="pubmed">32868907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro F, Pennuto M. Post-translational modifications and protein quality control in motor neuron and polyglutamine diseases. Front. Mol. Neurosci. 2017;10:82. doi: 10.3389/fnmol.2017.00082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00082</ArticleId><ArticleId IdType="pmc">PMC5374214</ArticleId><ArticleId IdType="pubmed">28408866</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Palazzolo I, Poletti A. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum. Mol. Genet. 2009;18:R40&#x2013;R47. doi: 10.1093/hmg/ddn412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn412</ArticleId><ArticleId IdType="pubmed">19297400</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 2003;23:2203&#x2013;2211. doi: 10.1523/JNEUROSCI.23-06-02203.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-06-02203.2003</ArticleId><ArticleId IdType="pmc">PMC6742038</ArticleId><ArticleId IdType="pubmed">12657679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara K, et al. Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J. Biol. Chem. 2003;278:25143&#x2013;25150. doi: 10.1074/jbc.M302975200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302975200</ArticleId><ArticleId IdType="pubmed">12714591</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl Acad. Sci. USA. 2005;102:16801&#x2013;16806. doi: 10.1073/pnas.0506249102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506249102</ArticleId><ArticleId IdType="pmc">PMC1275598</ArticleId><ArticleId IdType="pubmed">16260738</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009;18:1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr CR, et al. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J. Biol. Chem. 2010;285:35567&#x2013;35577. doi: 10.1074/jbc.M110.146845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.146845</ArticleId><ArticleId IdType="pmc">PMC2975181</ArticleId><ArticleId IdType="pubmed">20826791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zboray L, et al. Preventing the androgen receptor N/C Interaction Delays Disease Onset in a Mouse Model of SBMA. Cell Rep. 2015;13:2312&#x2013;2323. doi: 10.1016/j.celrep.2015.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.019</ArticleId><ArticleId IdType="pmc">PMC4684905</ArticleId><ArticleId IdType="pubmed">26673324</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, et al. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum. Mol. Genet. 2007;16:1593&#x2013;1603. doi: 10.1093/hmg/ddm109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm109</ArticleId><ArticleId IdType="pubmed">17470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Migazzi A, et al. Huntingtin-mediated axonal transport requires arginine methylation by PRMT6. Cell Rep. 2021;35:108980. doi: 10.1016/j.celrep.2021.108980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108980</ArticleId><ArticleId IdType="pmc">PMC8132453</ArticleId><ArticleId IdType="pubmed">33852844</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, et al. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis. Autophagy. 2019;15:1069&#x2013;1081. doi: 10.1080/15548627.2019.1569931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569931</ArticleId><ArticleId IdType="pmc">PMC6526864</ArticleId><ArticleId IdType="pubmed">30653406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosic M, et al. Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells. Nat. Commun. 2018;9:366. doi: 10.1038/s41467-017-02740-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02740-5</ArticleId><ArticleId IdType="pmc">PMC5785540</ArticleId><ArticleId IdType="pubmed">29371665</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenantin AC, et al. Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy. J. Clin. Invest. 2021;131:e136488. doi: 10.1172/JCI136488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI136488</ArticleId><ArticleId IdType="pmc">PMC7773358</ArticleId><ArticleId IdType="pubmed">33393499</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo JL, et al. Myofibroblast deficiency of LSD1 alleviates TAC-induced heart failure. Circ. Res. 2021;129:400&#x2013;413. doi: 10.1161/CIRCRESAHA.120.318149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.318149</ArticleId><ArticleId IdType="pubmed">34078090</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N. Engl. J. Med. 2022;387:1099&#x2013;1110. doi: 10.1056/NEJMoa2204705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204705</ArticleId><ArticleId IdType="pubmed">36129998</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust KD, et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. 2013;21:2148&#x2013;2159. doi: 10.1038/mt.2013.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId><ArticleId IdType="pmc">PMC3863799</ArticleId><ArticleId IdType="pubmed">24008656</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev. Med. Devices. 2013;10:781&#x2013;811. doi: 10.1586/17434440.2013.855471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17434440.2013.855471</ArticleId><ArticleId IdType="pubmed">24195461</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Lebron E, et al. Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice. Mol. Ther. 2013;21:1909&#x2013;1918. doi: 10.1038/mt.2013.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.152</ArticleId><ArticleId IdType="pmc">PMC3808130</ArticleId><ArticleId IdType="pubmed">23820820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran PS, Boudreau RL, Schaefer KA, La Spada AR, Davidson BL. Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7. Mol. Ther. 2014;22:1635&#x2013;1642. doi: 10.1038/mt.2014.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.108</ArticleId><ArticleId IdType="pmc">PMC4435484</ArticleId><ArticleId IdType="pubmed">24930601</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat. Med. 2022;28:104&#x2013;116. doi: 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride JL, et al. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington&#x2019;s disease. Mol. Ther. 2011;19:2152&#x2013;2162. doi: 10.1038/mt.2011.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2011.219</ArticleId><ArticleId IdType="pmc">PMC3242667</ArticleId><ArticleId IdType="pubmed">22031240</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H, et al. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat. Med. 2022;28:117&#x2013;124. doi: 10.1038/s41591-021-01557-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01557-6</ArticleId><ArticleId IdType="pmc">PMC8861976</ArticleId><ArticleId IdType="pubmed">34949835</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal T, et al. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:1929&#x2013;1938. doi: 10.1016/j.neurobiolaging.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.004</ArticleId><ArticleId IdType="pubmed">24630363</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgia D, et al. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. Hum. Mol. Genet. 2017;26:1087&#x2013;1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409076</ArticleId><ArticleId IdType="pubmed">28087734</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourshafie N, et al. Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons. JCI Insight. 2020;5:e136539. doi: 10.1172/jci.insight.136539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.136539</ArticleId><ArticleId IdType="pmc">PMC7406250</ArticleId><ArticleId IdType="pubmed">32641584</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci. Transl. Med. 2016;8:370ra181. doi: 10.1126/scitranslmed.aaf9526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf9526</ArticleId><ArticleId IdType="pubmed">28003546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy D, et al. Mutations in TGM6 induce the unfolded protein response in SCA35. Hum. Mol. Genet. 2017;26:3749&#x2013;3762. doi: 10.1093/hmg/ddx259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx259</ArticleId><ArticleId IdType="pubmed">28934387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kechin A, Boyarskikh U, Kel A, Filipenko M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J. Comput Biol. 2017;24:1138&#x2013;1143. doi: 10.1089/cmb.2017.0096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/cmb.2017.0096</ArticleId><ArticleId IdType="pubmed">28715235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter D, Dormann HL, Allis CD, Hake SB. Extraction, purification and analysis of histones. Nat. Protoc. 2007;2:1445&#x2013;1457. doi: 10.1038/nprot.2007.202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.202</ArticleId><ArticleId IdType="pubmed">17545981</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrini M, et al. Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome. Mol. Ther. 2021;29:3072&#x2013;3092. doi: 10.1016/j.ymthe.2021.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.05.023</ArticleId><ArticleId IdType="pmc">PMC8531145</ArticleId><ArticleId IdType="pubmed">34058387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KH, et al. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 2006;34:e53. doi: 10.1093/nar/gkl143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl143</ArticleId><ArticleId IdType="pmc">PMC1435982</ArticleId><ArticleId IdType="pubmed">16614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso E, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 2010;17:503&#x2013;510. doi: 10.1038/gt.2009.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2009.157</ArticleId><ArticleId IdType="pubmed">19956269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>